This inventor holds 1 USPTO granted patent. Top assignee: Yunbaiyao Zhengwu Science and Technology (Shanghai) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Yinshuang Wu
Introduction
Yinshuang Wu is a notable inventor based in Kunming, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His work exemplifies the intersection of innovation and practical application in medical science.
Latest Patents
Yinshuang Wu holds a patent for an imidazotriazine thiobenzamide derivative, which is a compound that has potential applications in the treatment of cancer. The patent outlines a preparation method for this derivative and discusses its use in developing drugs aimed at combating cancer. This innovative approach highlights the importance of chemical derivatives in advancing therapeutic options.
Career Highlights
Wu's career is marked by his dedication to research and development in the pharmaceutical industry. He is currently associated with Yunbaiyao Zhengwu Science and Technology (Shanghai) Co., Ltd., where he continues to explore new avenues for drug development. His work is characterized by a commitment to improving health outcomes through innovative solutions.
Collaborations
Yinshuang Wu collaborates with esteemed colleagues such as Zhengwu Shen and Bin Deng. These partnerships enhance the research environment and foster the exchange of ideas, which is crucial for innovation in the pharmaceutical sector.
Conclusion
Yinshuang Wu's contributions to the field of pharmaceuticals, particularly through his patent on imidazotriazine thiobenzamide derivatives, underscore his role as a key innovator in cancer treatment. His ongoing work at Yunbaiyao Zhengwu Science and Technology (Shanghai) Co., Ltd. continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile